Av. de Huelva, 8. 06005 Badajoz

info@areasaludbadajoz.com

info@areasaludbadajoz.com

Search
Imagen Repositorio

Resultado
de búsqueda

2020/01
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019) [published online ahead of print, 2020 Jan 24]. Clin Transl Oncol. 2020;10.1007/s12094-019-02263-z. doi:10.1007/s12094-019-02263-z.f.I.3.138
Autores/as:
Muñoz Martín AJ, Gallardo Díaz E, García Escobar I, Macías Montero R, Martínez-Marín V, Pachón Olmos V, Pérez Segura P, Quintanar Verdúguez T, Salgado Fernández M

Servicio:

Oncología.- Complejo Hospitalario Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://pubmed.ncbi.nlm.nih.gov/31981080-seom-clinical-guideline-of-venous-thromboembolism-vte-and-cancer-2019/?from_term=Badajoz%252B2020%25252F01&from_page=2&from_pos=10″}
2020/01
Impact of cardiovascular risk factors in the Extremadura population: HERMEX cohort contributions for a preventive strategy]. Aten Primaria. 2020 Jan;52(1):3-13. Spanish. doi: 10.1016/j.aprim.2018.11.006. Epub 2019 Jan 10. PMID: 30638699; PMCID: PMC6938985.F.I.:1.346.
Autores/as:
Félix-Redondo FJ, Lozano Mera L, Alvarez-Palacios Arrighi P, Grau Magana M, Ramírez-Romero JM, Fernández-Bergés D.

Servicio:

Neurología- Complejo Hospitalario Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://pubmed.ncbi.nlm.nih.gov/30638699-impact-of-cardiovascular-risk-factors-in-the-extremadura-population-hermex-cohort-contributions-for-a-preventive-strategy/?from_term=badajoz%252B2020%25252F01&from_size=50&from_page=1&from_pos=5″}
2020/01
Does established vascular kidney disease exist? J Clin Hypertens (Greenwich). 2020 Jan 31;10.1111/jch.13818. doi: 10.1111/jch.13818. [Epub ahead of print]. PMID: 32003932.F.I.:2.444
Autores/as:
Robles NR, Fici F, Ari Bakir E, Grassi G

Servicio:

Nefrología Complejo Hospitlario Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://pubmed.ncbi.nlm.nih.gov/32003932-does-established-vascular-kidney-disease-exist/?from_term=badajoz%252B2020%25252F01&from_size=50&from_page=1&from_pos=26″}
2020/01
PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease. High Blood Press Cardiovasc Prev. 2020 Jan 9;10.1007/s40292-020-00358-1. doi: 10.1007/s40292-020-00358-1. [Epub ahead of print]. PMID: 31916208.F.I.:1.200
Autores/as:
Fici F, Ari Bakir E, Ilkay Yüce E, Kanuncu S, Makel W, Tarim BA, Robles NR

Servicio:

Nefrología Complejo Hospitlario Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://pubmed.ncbi.nlm.nih.gov/31916208-pait-survey-follow-up-changes-in-albuminuria-in-hypertensive-diabetic-patients-with-mild-moderate-chronic-kidney-disease/?from_term=badajoz%252B2020%25252F01&from_size=50&from_page=1&from_pos=24″}
2020/01
Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment? Nefrologia. 2020 Jan – Feb;40(1):38-45. doi: 10.1016/j.nefro.2019.02.013. Epub 2019 Jun 10. English, Spanish.PMID:31196659.F.I.:1.439
Autores/as:
Caravaca-Fontán F, Valladares J, Díaz-Campillejo R, Barroso S, Luna E, Caravaca F.

Servicio:

Nefrología Complejo Hospitlario Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://www.ncbi.nlm.nih.gov/pubmed/31196659″}
2020/01
Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease. Atherosclerosis. 2020 Jan;292:84-89. doi: 10.1016/j.atherosclerosis.2019.11.002. Epub 2019 Nov 16.PMID:31785493.F.I.:4.255.
Autores/as:
Muñoz-Torrero JFS, Zamorano J, Rico-Martín S, Rivas MD, Bacaicoa MA, Robles R, Sanchez-Bacaicoa C, Monreal M;

Servicio:

Nefrología Complejo Hospitlario Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://www.ncbi.nlm.nih.gov/pubmed/31785493/»}
2020/01
C>A substitution in NT 46 of the 3′ UTR region (the α complex protected region) of the alpha-1 globin gene: a non-deletional mutation or polymorphism? J Clin Pathol. 2020 Jan;73(1):14-16. doi: 10.1136/jclinpath-2019-206004. Epub 2019 Aug 21. PMID: 31434698.F.I.:2.346
Autores/as:
Ropero P, González FA, Nieto JM, Villegas A, Sevilla J, Pérez G, Alonso JM, Recasens V, Abio M, Vagace JM, Vanegas RJ, González Fernández B, Martínez R

Servicio:

Hematología Hospital Materno Infantil de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://pubmed.ncbi.nlm.nih.gov/31434698-ca-substitution-in-nt-46-of-the-3-utr-region-the-complex-protected-region-of-the-alpha-1-globin-gene-a-non-deletional-mutation-or-polymorphism/?from_term=badajoz%252B2020%25252F01&from_size=50&from_page=1&from_pos=41″}
2020/01
Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia. BMJ Open. 2020 Jan 8;10(1):e029642. doi: 10.1136/bmjopen-2019-029642. PMID: 31919123; PMCID: PMC6955478. F.I.:2.376.
Autores/as:
Muñoz Builes M, Vela Cuenca M, Fuster Soler JL, Astigarraga I, Pascual Martínez A, Vagace Valero JM, Tong HY, Valentín Quiroga J, Fernández Casanova L, Escudero López A, Sisinni L, Blanquer M, Mirones Aguilar I, González Martínez B, Borobia AM, Pérez-Martínez A.

Servicio:

Hematología Hospital Materno Infantil de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://pubmed.ncbi.nlm.nih.gov/31919123-study-protocol-for-a-phase-ii-multicentre-prospective-non-randomised-clinical-trial-to-assess-the-safety-and-efficacy-of-infusing-allogeneic-activated-and-expanded-natural-killer-cells-as-consolidation-therapy-for/»}
2020/01
C>A substitution in NT 46 of the 3′ UTR region (the α complex protected region) of the alpha-1 globin gene: a non-deletional mutation or polymorphism? J  Clin Pathol. 2020 Jan;73(1):14-16. doi: 10.1136/jclinpath-2019-206004. Epub 2019 Aug 21.PMID:31434698.F.I.: 2.346
Autores/as:
Ropero P, González FA, Nieto JM, Villegas A, Sevilla J, Pérez G, Alonso JM, Recasens V, Abio M, Vagace JM, Vanegas RJ, González Fernández B, Martínez R

Servicio:

Hematología Hospital Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://www.ncbi.nlm.nih.gov/pubmed/31434698″}
2020/01
Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia. BMJ Open. 2020 Jan 8;10(1):e029642. doi: 10.1136/bmjopen-2019-029642.PMID:31919123.F.I.: 2.37
Autores/as:
Muñoz Builes M, Vela Cuenca M, Fuster Soler JL, Astigarraga I, Pascual Martínez A, Vagace Valero JM, Tong HY, Valentín Quiroga J, Fernández Casanova L, Escudero López A, Sisinni L, Blanquer M, Mirones Aguilar I, González Martínez B, Borobia AM, Pérez-Martínez A

Servicio:

Hematología Hospital Universitario de Badajoz

Tipo:

Artículo

Materia:

{«label»:»Resumen Pubmed»,»link»:»https://www.ncbi.nlm.nih.gov/pubmed/31919123″}